Pro-inflammatory miR-223 mediates the cross-talk between the IL23 pathway and the intestinal barrier in inflammatory bowel disease.
about
Integrated host and viral transcriptome analyses reveal pathology and inflammatory response mechanisms to ALV-J injection in SPF chickensLactobacillus rhamnosus GG supernatant enhance neonatal resistance to systemic Escherichia coli K1 infection by accelerating development of intestinal defenseDecreased expression of protocadherin 20 is associated with poor prognosis in hepatocellular carcinoma.Upregulation of miR-665 promotes apoptosis and colitis in inflammatory bowel disease by repressing the endoplasmic reticulum stress components XBP1 and ORMDL3.Disruption of the epithelial barrier during intestinal inflammation: Quest for new molecules and mechanisms.Role of MiRNAs in Inflammatory Bowel Disease.rSj16 Protects against DSS-Induced Colitis by Inhibiting the PPAR-α Signaling Pathway.MicroRNA exhibit altered expression in the inflamed colonic mucosa of ulcerative colitis patients.miR-223 promotes colon cancer by directly targeting p120 catenin.MicroRNA expression changes in association with changes in interleukin-1ß/interleukin10 ratios produced by monocytes in autism spectrum disorders: their association with neuropsychiatric symptoms and comorbid conditions (observational study).MicroRNAs in intestinal barrier function, inflammatory bowel disease and related cancers-their effects and therapeutic potentials.Oral probiotic treatment of Lactobacillus rhamnosus Lcr35® prevents visceral hypersensitivity to a colonic inflammation and an acute psychological stress.Tumor necrosis factor-α acts reciprocally with solute carrier family 26, member 3, (downregulated-in-adenoma) and reduces its expression, leading to intestinal inflammation.Functional role and therapeutic targeting of microRNAs in inflammatory bowel disease.miR-148a inhibits colitis and colitis-associated tumorigenesis in mice.MicroRNA-mediated dynamic control of mucosal immunity.Targeting the IGF1R Pathway in Breast Cancer Using Antisense lncRNA-Mediated Promoter cis Competition.
P2860
Q33555505-559B40F9-B388-40A4-AB30-2DCA2DE26142Q37681849-7A63B51D-BCBB-4807-BDE0-15E566906421Q37709418-E2488086-EDA5-482E-98A0-5A0683F48CB0Q37745551-06D0C1BD-07AA-49B1-9111-02F14312DBEFQ39189861-28D4B9EB-D332-4A01-9A3F-885E8EC2F09AQ39229393-AA1F8971-6456-4B1E-ABAC-239FAF1A75D8Q41174308-CEFDE329-BF87-438F-9D37-7EEA3AD8C403Q41334648-7F66EF71-B591-44F8-8B39-80AF88B7BB30Q42362761-75CD679D-2FA3-4167-B2B8-E6FD0A8CF8D3Q47096880-1FAC5511-ABB2-4421-AFD8-3EB636928908Q47386784-733D307C-42A2-4B98-899C-5D009830C9CCQ48313903-A34701FC-3F71-45F2-8D1F-F9AB1FC7C531Q49500705-975AC25F-A45E-4812-8649-CE0B56A104B9Q49953206-3A23A4F1-498B-4704-85B8-EB6814AEFB95Q52484095-BF9337B5-AEBF-4230-A274-4C2A454C91A5Q52688461-50426A1C-3BF9-42AC-B630-F5F8A6AEC74AQ55438295-6ED71284-AB70-4B83-B353-A2F28A243514
P2860
Pro-inflammatory miR-223 mediates the cross-talk between the IL23 pathway and the intestinal barrier in inflammatory bowel disease.
description
2016 nî lūn-bûn
@nan
2016年の論文
@ja
2016年論文
@yue
2016年論文
@zh-hant
2016年論文
@zh-hk
2016年論文
@zh-mo
2016年論文
@zh-tw
2016年论文
@wuu
2016年论文
@zh
2016年论文
@zh-cn
name
Pro-inflammatory miR-223 media ...... in inflammatory bowel disease.
@en
type
label
Pro-inflammatory miR-223 media ...... in inflammatory bowel disease.
@en
prefLabel
Pro-inflammatory miR-223 media ...... in inflammatory bowel disease.
@en
P2093
P2860
P1433
P1476
Pro-inflammatory miR-223 media ...... in inflammatory bowel disease.
@en
P2093
Alfa Hc Bai
Huiling Wang
Manying Li
Minhu Chen
Shenghong Zhang
Siew Chien Ng
P2860
P2888
P356
10.1186/S13059-016-0901-8
P577
2016-03-30T00:00:00Z
P6179
1020928997